J9226 HCPCS Level II code: Histrelin implant (supprelin la), 50 mg
J9226 is the HCPCS code for “Histrelin implant (supprelin la), 50 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J9226Histrelin implant (supprelin la), 50 mg
Short description: Supprelin la implant
HCPCS · United States
Medicare details
The indicators CMS publishes with J9226 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Chemotherapy
- Added
- Jan 1, 2008
Where J9226 sits
- 1J codesDrugs administered other than orally
- 2Active code J9226Histrelin implant (supprelin la), 50 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J9226 mean?
J9226 is the HCPCS code for “Histrelin implant (supprelin la), 50 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J9226?
CMS lists J9226’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J9226
All J codesJ9217Leuprolide acetate (for depot suspension), 7.5 mgJ9218Leuprolide acetate, per 1 mgJ9219Leuprolide acetate implant, 65 mgJ9220Injection, indigotindisulfonate sodium, 1 mgJ9223Injection, lurbinectedin, 0.1 mgJ9225Histrelin implant (vantas), 50 mgJ9227Injection, isatuximab-irfc, 10 mgJ9228Injection, ipilimumab, 1 mgJ9229Injection, inotuzumab ozogamicin, 0.1 mgJ9230Injection, mechlorethamine hydrochloride, (nitrogen mustard), 10 mgJ9232Injection, docetaxel (hospira), not therapeutically equivalent to j9171, 1 mgJ9245Injection, melphalan hydrochloride, not otherwise specified, 50 mg